Although PLXNA4 is predominantly downregulated in several tumors [39], its inhibition in U87-MG glioma cells reduces their proliferation and tumor-forming capacity, suggesting that PLXNA4 promotes tumor progression [40]. Here, PLXNA4 is linked to central nervous system cancer.